Ransohoff RM - Search Results

1

Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.

Rudick RA, Pace A, Rani MR, Hyde R, Panzara M, Appachi S, Shrock J, Maurer SL, Calabresi PA, Confavreux C, Galetta SL, Lublin FD, Radue EW, Ransohoff RM. Rudick RA, et al. Among authors: ransohoff rm. Neurology. 2009 Jun 9;72(23):1989-93. doi: 10.1212/WNL.0b013e3181a92b96. Neurology. 2009. PMID: 19506220 Free PMC article. Clinical Trial.

2

Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity.

Rudick RA, Ransohoff RM. Rudick RA, et al. Among authors: ransohoff rm. Arch Neurol. 1992 Mar;49(3):265-70. doi: 10.1001/archneur.1992.00530270079022. Arch Neurol. 1992. PMID: 1536629

3

The interferons: biological effects, mechanisms of action, and use in multiple sclerosis.

Weinstock-Guttman B, Ransohoff RM, Kinkel RP, Rudick RA. Weinstock-Guttman B, et al. Among authors: ransohoff rm. Ann Neurol. 1995 Jan;37(1):7-15. doi: 10.1002/ana.410370105. Ann Neurol. 1995. PMID: 7529476 Review. No abstract available.

4

In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta.

Rudick RA, Carpenter CS, Cookfair DL, Tuohy VK, Ransohoff RM. Rudick RA, et al. Among authors: ransohoff rm. Neurology. 1993 Oct;43(10):2080-7. doi: 10.1212/wnl.43.10.2080. Neurology. 1993. PMID: 8105424 Clinical Trial.

5

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis.

Rudick RA, Ransohoff RM, Peppler R, VanderBrug Medendorp S, Lehmann P, Alam J. Rudick RA, et al. Among authors: ransohoff rm. Ann Neurol. 1996 Oct;40(4):618-27. doi: 10.1002/ana.410400412. Ann Neurol. 1996. PMID: 8871582

6

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis.

Rudick RA, Ransohoff RM, Lee JC, Peppler R, Yu M, Mathisen PM, Tuohy VK. Rudick RA, et al. Among authors: ransohoff rm. Neurology. 1998 May;50(5):1294-300. doi: 10.1212/wnl.50.5.1294. Neurology. 1998. PMID: 9595977 Clinical Trial.

7

Experimental therapies for multiple sclerosis: current status.

Goodkin DE, Ransohoff RM, Rudick RA. Goodkin DE, et al. Among authors: ransohoff rm. Cleve Clin J Med. 1992 Jan-Feb;59(1):63-74. doi: 10.3949/ccjm.59.1.63. Cleve Clin J Med. 1992. PMID: 1372538 Free article. Review.

8

Diagnostic criteria for multiple sclerosis research involving multiply affected families.

Goodkin DE, Doolittle TH, Hauser SS, Ransohoff RM, Roses AD, Rudick RA. Goodkin DE, et al. Among authors: ransohoff rm. Arch Neurol. 1991 Aug;48(8):805-7. doi: 10.1001/archneur.1991.00530200041016. Arch Neurol. 1991. PMID: 1898254

9

Stereotactic biopsy of an active multiple sclerosis lesion. Immunocytochemical analysis and neuropathologic correlation with magnetic resonance imaging.

Estes ML, Rudick RA, Barnett GH, Ransohoff RM. Estes ML, et al. Among authors: ransohoff rm. Arch Neurol. 1990 Dec;47(12):1299-303. doi: 10.1001/archneur.1990.00530120043008. Arch Neurol. 1990. PMID: 1979221

10

Heat-shock proteins and autoimmunity: implications for multiple sclerosis.

Ransohoff RM, Rudick RA. Ransohoff RM, et al. Ann Neurol. 1993 Jul;34(1):5-7. doi: 10.1002/ana.410340104. Ann Neurol. 1993. PMID: 8517680 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters